These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 11446524
1. A controlled trial of a critical pathway for treating community-acquired pneumonia: the CAPITAL study. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. Feagan BG. Pharmacotherapy; 2001 Jul; 21(7 Pt 2):89S-94S. PubMed ID: 11446524 [Abstract] [Full Text] [Related]
2. Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin. Palmer CS, Zhan C, Elixhauser A, Halpern MT, Rance L, Feagan BG, Marrie TJ. Clin Ther; 2000 Feb; 22(2):250-64. PubMed ID: 10743984 [Abstract] [Full Text] [Related]
3. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. JAMA; 2000 Feb 09; 283(6):749-55. PubMed ID: 10683053 [Abstract] [Full Text] [Related]
4. Intravenous-to-oral transition therapy in community-acquired pneumonia: the INOVA Health System experience. Milkovich G. Pharmacotherapy; 2001 Jul 09; 21(7 Pt 2):83S-88S. PubMed ID: 11446523 [Abstract] [Full Text] [Related]
5. Approaches to drug therapy, formulary, and pathway management in a large community hospital. Halley HJ. Am J Health Syst Pharm; 2000 Nov 15; 57 Suppl 3():S17-21. PubMed ID: 11098316 [Abstract] [Full Text] [Related]
6. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W. Curr Med Res Opin; 2008 Mar 15; 24(3):895-906. PubMed ID: 18419876 [Abstract] [Full Text] [Related]